Evidence map›Paper›PMID 32341115›Full record

ReviewInfection and immunity2020

The Potential Role of Schistosome-Associated Factors as Therapeutic Modulators of the Immune System.

Junhui Li, Hong Liu, Jie Jiang, Xingguo She, Ying Niu, Yingzi Ming

Open access · bronzeAbstract readReview
In one paragraph

Review in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Junhui LiCenter for Organ Transplantation, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hong LiuCenter for Organ Transplantation, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jie JiangCenter for Organ Transplantation, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xingguo SheCenter for Organ Transplantation, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ying NiuCenter for Organ Transplantation, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yingzi MingCenter for Organ Transplantation, Third Xiangya Hospital, Central South University, Changsha, Hunan, China myz_china@aliyun.com.
Central South University · CNThird Xiangya Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The parasites and eggs of helminths, including schistosomes, are associated with factors that can modulate the nature and outcomes of host immune responses, particularly enhancing type 2 immunity and impairing the effects of type 1 and type 17 immunity. The main species of schistosomes that cause infection in humans are capable of generating a microenvironment that allows survival of the parasite by evasion of the immune response. Schistosome infections are associated with beneficial effects on chronic immune disorders, including allergies, autoimmune diseases, and alloimmune responses. Recently, there has been increasing research interest in the role of schistosomes in immunoregulation during human infection, and the mechanisms underlying these roles continue to be investigated. Further studies may identify potential opportunities to develop new treatments for immune disease. In this review, we provide an update on the advances in our understanding of schistosome-associated modulation of the cells of the innate and adaptive immune systems as well as the potential role of schistosome-associated factors as therapeutic modulators of immune disorders, including allergies, autoimmune diseases, and transplant immunopathology. We also discuss potential opportunities for targeting schistosome-induced immunoregulation for future translation to the clinical setting.

Indexed as

Adaptive ImmunityAnimalsAutoimmune DiseasesHypersensitivityImmune EvasionImmunity, InnateImmunologic FactorsImmunomodulationImmunotherapyOrgan TransplantationSchistosoma japonicumSchistosoma mansoniSchistosomiasisTh17 CellsTh1 CellsTh2 CellsImmunologic Factorsimmune disordersimmune therapyimmunomodulationschistosometype 2 helper T cells

Identifiers

PMID32341115
PMCPMC7375771
OpenAlexW3017822181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.